secwatch.observer — SEC 8-K summary
======================================

Issuer:     Molecular Templates, Inc. (—)
CIK:        0001183765
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001193125-24-079769
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Molecular Templates announces $9.5M private placement offering, amends second tranche of July 2023 deal
--------------------------------------------------------------------------------

- Gross proceeds of $9.5M from amended second tranche; issuing 1.21M common shares, 2.46M prefunded warrants, and 7.34M common warrants at combined $2.60 per share and warrant.
- Financing led by existing investor BVF Partners with BB Biotech AG and Santé.
- Anticipated closing April 2, 2024; net proceeds to fund clinical studies, working capital, and general corporate purposes.
- Stifel acting as sole placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1183765/000119312524079769/0001193125-24-079769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1183765/000119312524079769/d800096d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-079769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer